Ahmed Mousa is Vice President Licensing, IP & Legal Affairs at Pieris Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics in anemia, asthma, and cancer based on its proprietary Anticalin® platform. Ahmed is responsible for all legal and IP activities at Pieris, including management of the company’s patent portfolio and global prosecution. Prior to joining Pieris, Ahmed was an Associate with the law firm Covington & Burling LLP, representing pharmaceutical and biotechnology companies and focusing in IP litigation and transactions. Ahmed was also previously a law clerk at the U.S. Court of Appeals for the Third Circuit and an IP Associate at Kirkland & Ellis LLP. Ahmed obtained undergraduate degrees in Molecular Biology and Government from Cornell University. Prior to his legal career, Ahmed was a research scientist with a focus in tumor biology and angiogenesis. Ahmed graduated from Georgetown Law with honors, where he was the Editor-in-Chief of the Georgetown Journal of International Law.